ONGERICIMAB

UNII: X126G5DZ36
Preferred Substance Name: ONGERICIMAB

2145096-91-7
IMMUNOGLOBULIN G4, ANTI-(NEURAL APOPTOSIS-REGULATED CONVERTASE 1) (HUMAN MONOCLONAL JS002 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS002 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENSPCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC1, NARC-1, PROPROTEIN CONVERTASE 9, PC9)), HUMANIZED MONOCLONAL ANTIBODY
JS 002
JS002
JS-002
ONGERICIMAB [INN]
ONGERICIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

ONGERICIMAB

Synonyms and Mappings

Resources

Note